The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 6,009 | 148,000 | SH | SOLE | 148,000 | 0 | 0 | ||
| ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 5,649 | 90,000 | SH | SOLE | 90,000 | 0 | 0 | ||
| AVEXIS INC | COM | 05366U100 | 1,716 | 63,000 | SH | SOLE | 63,000 | 0 | 0 | ||
| BEIGENE LTD | SPONSORED ADR | 07725L102 | 953 | 32,500 | SH | SOLE | 32,500 | 0 | 0 | ||
| BIOGEN INC | COM | 09062X103 | 1,302 | 5,000 | SH | SOLE | 5,000 | 0 | 0 | ||
| BLUEBIRD BIO INC | COM | 09609G100 | 5,100 | 120,000 | SH | SOLE | 120,000 | 0 | 0 | ||
| BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 5,799 | 321,300 | SH | SOLE | 321,300 | 0 | 0 | ||
| BRISTOL MYERS SQUIBB CO | COM | 110122108 | 1,341 | 21,000 | SH | SOLE | 21,000 | 0 | 0 | ||
| CYTOMX THERAPEUTICS INC | COM | 23284F105 | 4,141 | 321,023 | SH | SOLE | 321,023 | 0 | 0 | ||
| DEXCOM INC | COM | 252131107 | 2,716 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
| EDITAS MEDICINE INC | COM | 28106W103 | 2,952 | 85,470 | SH | SOLE | 85,470 | 0 | 0 | ||
| EPIZYME INC | COM | 29428V104 | 6,605 | 545,000 | SH | SOLE | 545,000 | 0 | 0 | ||
| EXACT SCIENCES CORP | COM | 30063P105 | 404 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
| FOUNDATION MEDICINE INC | COM | 350465100 | 6,090 | 335,000 | SH | SOLE | 335,000 | 0 | 0 | ||
| GENOMIC HEALTH INC | COM | 37244C101 | 1,362 | 55,000 | SH | SOLE | 55,000 | 0 | 0 | ||
| GLOBAL BLOOD THERAPEUTICS IN | COM | 37890U108 | 1,665 | 105,000 | SH | SOLE | 105,000 | 0 | 0 | ||
| IGNYTA INC | COM | 451731103 | 745 | 110,000 | SH | SOLE | 110,000 | 0 | 0 | ||
| KITE PHARMA INC | COM | 49803L109 | 3,443 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
| LOXO ONCOLOGY INC | COM | 548862101 | 6,835 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| MEDIDATA SOLUTIONS INC | COM | 58471A105 | 387 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
| MYOKARDIA INC | COM | 62857M105 | 5,091 | 475,350 | SH | SOLE | 475,350 | 0 | 0 | ||
| OXFORD IMMUNOTEC GLOBAL PLC | ORD SHS | G6855A103 | 198 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
| SAGE THERAPEUTICS INC | COM | 78667J108 | 6,059 | 189,000 | SH | SOLE | 189,000 | 0 | 0 | ||
| SPARK THERAPEUTICS INC | COM | 84652J103 | 5,017 | 170,000 | SH | SOLE | 170,000 | 0 | 0 | ||
| SPDR SERIES TRUST | S&P BIOTECH | 78464A870 | 2,583 | 50,000 | SH | Put | SOLE | 50,000 | 0 | 0 | |
| VOYAGER THERAPEUTICS INC | COM | 92915B106 | 2,963 | 339,362 | SH | SOLE | 339,362 | 0 | 0 | ||